Related Experiment Video
Updated: May 14, 2026
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Reduced expression of MIR409-3p in primary immune thrombocytopenia
Huiyuan Li1, Haifeng Zhao, Feng Xue
1State Key Laboratory of Experimental Haematology, Institute of Haematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Abstract:
Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease with many immune dysfunctions. MicroRNAs (miRNAs) are a class of non-coding RNAs that post-transcriptionally regulate gene expression by messenger RNA degradation or translational repression. Accumulating evidence has demonstrated that miRNAs play a vital role in the regulation of immunological functions and prevention of autoimmunity. However, whether miRNAs are involved in the pathogenesis of ITP is still unknown. To illustrate the role of miRNAs in ITP, the expression profile of miRNAs from peripheral blood mononuclear cells (PBMCs) in ITP patients was investigated by miRNA microarray, and further validated by TaqMan real-time polymerase chain reaction. MIR409-3p expression was decreased in PBMCs of active ITP patients, but this recovered after effective therapy. IFNG was identified and validated as one of the targeted genes of MIR409-3p by bioinformatic prediction and reporter gene analysis. In addition, we found DGCR8 transcript was down-regulated in ITP patients and positively correlated with MIR409-3p. Thus, in ITP patients, decreased DGCR8 leads to down-regulation of MIR409-3p, which in turn results in up-regulation of IFNG (IFN-γ).
Insights
MicroRNAs (miRNAs) are implicated in immune thrombocytopenia (ITP). Decreased MIR409-3p in ITP patients, linked to DGCR8, leads to increased IFNG, suggesting a novel pathogenic mechanism in this autoimmune disorder.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by immune system dysfunction.
- MicroRNAs (miRNAs) are crucial regulators of immune function and autoimmunity.
- The role of miRNAs in ITP pathogenesis remains largely unexplored.
Purpose of the Study:
- To investigate the role of miRNAs in the pathogenesis of primary immune thrombocytopenia (ITP).
- To identify specific miRNAs and their target genes involved in ITP.
- To elucidate the molecular mechanisms underlying miRNA dysregulation in ITP.
Main Methods:
- MicroRNA microarray analysis of peripheral blood mononuclear cells (PBMCs) from ITP patients.
- TaqMan real-time polymerase chain reaction (PCR) for miRNA expression validation.
- Bioinformatic prediction and reporter gene assays to identify miRNA targets.
- Analysis of DGCR8 transcript levels in ITP patients.
Main Results:
- MIR409-3p expression was significantly decreased in active ITP patients' PBMCs, with levels recovering after therapy.
- IFNG (Interferon-gamma) was identified as a direct target gene of MIR409-3p.
- DGCR8 transcript levels were down-regulated in ITP patients and positively correlated with MIR409-3p expression.
Conclusions:
- Decreased DGCR8 in ITP patients leads to reduced MIR409-3p levels.
- Down-regulation of MIR409-3p results in the up-regulation of its target gene, IFNG.
- This pathway highlights a novel mechanism in the pathogenesis of primary immune thrombocytopenia.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs